SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma--a Nordic Lymphoma Group study. - Wikidata - awgldk - TriplyDB

SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma--a Nordic Lymphoma Group study.

SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma--a Nordic Lymphoma Group study.

http://www.wikidata.org/entity/Q34803137

about

The role of targeted treatment in mantle cell lymphoma: is transplant dead or alive?Clinical impact of recurrently mutated genes on lymphoma diagnostics: state-of-the-art and beyond Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agents Cytoplasmic expression of C-MYC protein is associated with risk stratification of mantle cell lymphoma.DNA methylation and histone modifications regulate SOX11 expression in lymphoid and solid cancer cells.Identification of V-ATPase as a molecular sensor of SOX11-levels and potential therapeutic target for mantle cell lymphoma.Phase II trial of R-CHOP plus bortezomib induction therapy followed by bortezomib maintenance for newly diagnosed mantle cell lymphoma: SWOG S0601.Identification of miR-15b as a transformation-related factor in mantle cell lymphoma Role of allogeneic stem cell transplantation in mantle cell lymphoma.New Molecular Assay for the Proliferation Signature in Mantle Cell Lymphoma Applicable to Formalin-Fixed Paraffin-Embedded Biopsies.Novel agents in mantle cell lymphoma.Prognosis and outcome of stem cell transplantation for mantle cell lymphoma.Mantle cell lymphoma--a spectrum from indolent to aggressive disease.Novel targeted therapeutics for mantle cell lymphoma--what's on the horizon?Which Patients With Mantle Cell Lymphoma Do Not Need Aggressive Therapy.Role of SOX11 and Genetic Events Cooperating with Cyclin D1 in Mantle Cell Lymphoma.SOX11 regulates the pro-apoptosis signal pathway and predicts a favorable prognosis of mantle cell lymphoma.Recommendations for Clinical Trial Development in Mantle Cell Lymphoma.Early stages in the ontogeny of small B-cell lymphomas: genetics and microenvironment.Novel agents in mantle cell lymphoma.Current Status of Bruton's Tyrosine Kinase Inhibitor Development and Use in B-Cell Malignancies.Prognostic model for mantle cell lymphoma in the rituximab era: a nationwide study in Japan.Personalized medicine in lymphoma: is it worthwhile? The mantle cell lymphoma experience.The utility of mRNA analysis in defining SOX11 expression levels in mantle cell lymphoma and reactive lymph nodes.Long non-coding RNA profile in mantle cell lymphoma identifies a functional lncRNA ROR1-AS1 associated with EZH2/PRC2 complex.Smoldering mantle cell lymphoma.Pleomorphic mantle cell lymphoma morphologically mimicking diffuse large B cell lymphoma: common cyclin D1 negativity and a simple immunohistochemical algorithm to avoid the diagnostic pitfall.Potential added value of a RT-qPCR method of SOX 11 expression, in the context of a multidisciplinary diagnostic assessment of B cell malignancies.SOX11 and HIG-2 are cross-regulated and affect growth in mantle cell lymphoma.Leukemic non-nodal mantle cell lymphomas have a distinct phenotype and are associated with deletion of PARP1 and 13q14.Complex karyotype in patients with mantle cell lymphoma predicts inferior survival and poor response to intensive induction therapy.Bortezomib prevents cytarabine resistance in MCL, which is characterized by down-regulation of dCK and up-regulation of SPIB resulting in high NF-κB activity.MYC overexpression correlates with MYC amplification or translocation, and is associated with poor prognosis in mantle cell lymphoma.A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome

P2860

Q26772907-34CA4FD5-C3FA-4312-BFD8-9A7E3454D074 Q27027493-717DEB77-1504-4112-84E2-15754EA054AD Q28075606-9238C0F8-E092-4CCE-825D-73D6C2592B20 Q33802505-6F76FFBD-0F91-416F-A5D5-2B1448277A47 Q35492725-F6271BC0-2A5D-47F2-B1EE-03BB180B3799 Q36080584-9E590593-E5F8-4BCD-97A4-7E0A9D454745 Q36456078-3B2D821F-8CC7-4F49-8747-197A941D3884 Q36498093-62987265-9D74-4862-9518-76849CFBFABB Q38242980-F544E8D2-F9D2-48FE-85FA-08AC42C4DE2F Q38375603-6672836F-3FAF-455A-B2E3-D06A5D39361F Q38516704-6BB34C45-B789-481D-A128-503FC78DFA0D Q38532268-0B582E5D-06BE-4C3C-871F-05F14FE7A919 Q38571854-4714EC1C-B4C0-4BF7-8768-392470DBB123 Q38675161-BFEE0734-DDD3-4BB5-AE80-A23773637F14 Q38805552-ECBEC087-E46A-492B-B798-B654A8A42B3E Q38807612-F7D62D92-1A06-47EF-9D85-2C55FC7F76D9 Q38827399-104B8507-0AC1-4AA3-8481-9FE2993AAB2E Q39045701-B6405163-816C-4B06-AE96-D50C9EAE0F61 Q39230986-2ED61CA3-730D-46B0-9924-F243C838DEA9 Q39290199-FAAC472C-198E-4F47-9919-D850518F01D4 Q39325783-C8EBC6BF-3BC8-4304-9F04-D6F88FA1796B Q40962764-41AA90E9-B491-4354-8AE0-95089922455D Q42848307-30A02C6D-B143-4453-816A-BDE022CEBF84 Q42943352-54820CA9-92C6-4F87-8649-1E7CB4F3D9F3 Q45928054-4BCE1887-5725-4B30-8DE8-F78A15838C9E Q47111277-9CFB7A02-7CE8-40C6-AA2D-77F8FC1D19EA Q48027440-8132FB97-9ED6-448D-B6F3-DAEF969AF77D Q50350976-DBBC5C6A-BDE7-491A-864B-48A2E5E9CE18 Q50912495-D4D7FEC2-D72E-4C13-BA5E-6FD61E18C471 Q51529244-FDB5B1B1-3605-4D90-B499-56A0C9B8F760 Q52341659-CD0DC09B-28BF-4E8B-AC25-7EF824BD5070 Q52563154-70EBFE56-DD7E-4505-9F35-B0FD8D61FC32 Q53458473-356CB365-9F35-4FB2-B414-6706FB02DADF Q57759536-F8DDFAA0-36A6-4E2A-A18A-0666779B43CA

P2860

SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma--a Nordic Lymphoma Group study.

http://www.wikidata.org/entity/Q34803137

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

SOX11 and TP53 add prognostic ...... a Nordic Lymphoma Group study.

@ast

SOX11 and TP53 add prognostic ...... a Nordic Lymphoma Group study.

@en

SOX11 and TP53 add prognostic ...... a Nordic Lymphoma Group study.

@nl

type

label

SOX11 and TP53 add prognostic ...... a Nordic Lymphoma Group study.

@ast

SOX11 and TP53 add prognostic ...... a Nordic Lymphoma Group study.

@en

SOX11 and TP53 add prognostic ...... a Nordic Lymphoma Group study.

@nl

prefLabel

SOX11 and TP53 add prognostic ...... a Nordic Lymphoma Group study.

@ast

SOX11 and TP53 add prognostic ...... a Nordic Lymphoma Group study.

@en

SOX11 and TP53 add prognostic ...... a Nordic Lymphoma Group study.

@nl

P1433

Q34803137-4C315CAF-4206-4183-A43D-E9F6F475F8B0

P1476

Q34803137-C5466FD7-1622-469A-9B3B-7070608BF364

P2093

Q34803137-0CD42010-325D-426E-9642-460DE6E2E719

Q34803137-2F1F003B-257D-4373-BBC1-D4BCF008EABA

Q34803137-2FBE284A-6662-4838-B2D3-6B7089E0EB1C

Q34803137-38AB8588-D9A9-45E4-A11E-CC285A65E352

Q34803137-40EB8D90-D953-4F47-89F7-75165E5C3FA8

Q34803137-49129447-759A-4AF2-A45B-9A1CC34462E4

Q34803137-4B7547B3-25A7-42FC-98D6-F8EA13A9DE9B

Q34803137-6706C50F-65FA-487C-959A-9DCF77508015

Q34803137-A5585674-4F88-4AFA-9802-415BBC8878C8

Q34803137-AD55D3C2-E818-4E62-8BC6-768E13C0F859

P2860

Q34803137-093F817B-DD87-450A-A3F8-362F17FA70F8

Q34803137-0AE748EE-D2A6-45B0-9CBA-8C5EDBEC2BE7

Q34803137-1183674D-1348-4CE5-9BC5-C75611C9708A

Q34803137-1D2ED0F3-481E-4B7C-81C4-2A432DDAE818

Q34803137-405D19B0-E98E-40EA-A23F-A2FB7CBC5424

Q34803137-453EFF71-19F1-4AEE-A7F7-D9A6C4DBA446

Q34803137-4E19F06D-ACA2-4F10-A577-7F588ACB7220

Q34803137-5524EC1B-351B-43A1-8C3E-CEDD60826E61

Q34803137-5D1F7113-75CA-427F-9008-19A0C2EDA57C

Q34803137-62A22E64-09B1-4D28-85FF-E854F404BF42

P304

Q34803137-77CEDD18-49E7-4DB8-97AE-DD5E72904D48

P31

Q34803137-CA8E2B9C-2AFB-4DB3-9AC5-67AAB48F6E9A

P356

Q34803137-FD8FC706-D301-4408-A96B-0CD0A795877F

P407

Q34803137-FBCCF977-017D-4F70-85E9-56A2C06CE2BA

P433

Q34803137-55C6E0D2-A5C5-4B8B-B700-8DAD51F21171

P478

Q34803137-C209C7DA-6EF6-4CC2-8E4F-DEBE340B3478

P50

Q34803137-2FF8764D-AE0B-4309-AE58-3BAB04CE536D

Q34803137-5211A165-3151-4B39-A5C8-B0BFC8791568

Q34803137-8BF3315B-2876-4B71-8D07-9D5262A2A59E

Q34803137-B780D0D8-30E7-4ED7-BC0C-62F8073376BC

Q34803137-DAA42A86-77E9-4F2D-B442-F21E192722BD

P577

Q34803137-8FEF9BBF-F96D-4005-B1E9-CD89B97D0E42

P5875

Q34803137-3930359D-C632-4FBA-A1BD-4C2902309E84

P698

Q34803137-A4411278-E7E1-4B3A-8085-071D66C8AC54

P932

Q34803137-41E1ACC3-7A7E-4BD6-B451-06579F258F40

P356

P1433

British Journal of Haematology

P1476

SOX11 and TP53 add prognostic ...... a Nordic Lymphoma Group study.

@en

P2093

Anna Laurell

http://www.w3.org/2001/XMLSchema#string

Arne Kolstad

http://www.w3.org/2001/XMLSchema#string

Christer Sundström

http://www.w3.org/2001/XMLSchema#string

Christian Geisler

http://www.w3.org/2001/XMLSchema#string

Elisabeth Ralfkiaer

http://www.w3.org/2001/XMLSchema#string

Kirsten Grønbaek

http://www.w3.org/2001/XMLSchema#string

Lena Nordström

http://www.w3.org/2001/XMLSchema#string

Marja-Liisa Karjalainen

http://www.w3.org/2001/XMLSchema#string

Mats Ehinger

http://www.w3.org/2001/XMLSchema#string

Mats Jerkeman

http://www.w3.org/2001/XMLSchema#string

P2860

Improvement of Overall Survival in Advanced Stage Mantle Cell Lymphoma

Nuclear expression of the non B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma

SOX11 expression correlates to promoter methylation and regulates tumor growth in hematopoietic malignancies

A new look at the statistical model identification

A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma

Tissue microarrays for high-throughput molecular profiling of tumor specimens

Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma

Knock-down of SOX11 induces autotaxin-dependent increase in proliferation in vitro and more aggressive tumors in vivo.

Non-nodal type of mantle cell lymphoma is a specific biological and clinical subgroup of the disease.

Expanded clinical and experimental use of SOX11 - using a monoclonal antibody

P304

98-108

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BJH.12854

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

166

http://www.w3.org/2001/XMLSchema#string

P50

Elisabeth Ralfkiaer

Kirsten Grønbæk

Christian Geisler

P577

2014-03-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261254224

http://www.w3.org/2001/XMLSchema#string

P698

24684350

http://www.w3.org/2001/XMLSchema#string

P932

4282019

http://www.w3.org/2001/XMLSchema#string